EMCDDA Home
  • EN
Search

Drug-related infectious diseases (DRID)

Statistics found where the type is figure and where the category is Drug-related infectious diseases (INF)

Category Title Type
INF Figure INF-1. AIDS incidence by year of diagnosis among injecting drug users by country, cases per million, 1997 to 2007 figure
INF Figure INF-2. HIV infections newly diagnosed in injecting drug users, by year of report, by country, cases per million, number of newly diagnosed HIV infections and population sizes 2002–2007. EU countries, Croatia, Turkey and Norway Part (i) HIV newly diagnosed cases per million population in IDUs, by year and by country — five highest EU countries in peak value 2002-2007 figure
INF Figure INF-2. HIV infections newly diagnosed in injecting drug users, by year of report, by country, cases per million, number of newly diagnosed HIV infections and population sizes 2002–2007. EU countries, Croatia, Turkey and Norway. Part (ii) HIV newly diagnosed cases per million population in IDUs, by year and by country - other EU countries with peak > 1 case /M population 2002-2007 figure
INF Figure INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (i) All injecting drug users, 2006 and 2007 figure
INF Figure INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (ii) Young injecting drug users (under age 25), 2006 to 2007 figure
INF Figure INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (iii) New injecting drug users (less than 2 years since first injection), 2006 to 2007 figure
INF Figure INF-6. Estimated HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (i) Sample estimates, 2006 to 2007 figure
INF Figure INF-6. Estimated HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (ii) Estimates for the sub-sample of young injecting drug users (under age 25), 2006 to 2007 figure
INF Figure INF-6. Estimated HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (iii) Estimates for the sub-sample of new injecting drug users (injecting less than 2 years), 2006 to 2007 figure
INF Figure INF-9. Prevalence of markers of HBV infection estimated among national and subnational samples of injecting drug users 2006 to 2007, where data are available Part (i) Percentage positive for ever infected (aHBc) figure
INF Figure INF-9. Prevalence of markers of HBV infection estimated among national and subnational samples of injecting drug users 2006 to 2007, where data are available Part (ii) Percentage positive for current infection (HBsAg) figure

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 16 November 2009